Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

45.5K
VSEPR Theory for Determination of Electron Pair Geometries
45.5K
Prediction Intervals01:03

Prediction Intervals

3.3K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
3.3K
Transcription Factors02:16

Transcription Factors

82.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
End Point Prediction: Gran Plot01:07

End Point Prediction: Gran Plot

1.2K
A Gran plot is used to predict the equivalence volume or endpoint of a potentiometric or acid-base titration without reaching the endpoint. Typically, titration data is collected as a function of the titrant's volume up to a point less than the equivalence volume and then transformed into a linear format. The straight line is extended to the x-axis, indicating the necessary titrant volume to achieve the equivalence point.
For potentiometric titration, the Gran plot is created by plotting...
1.2K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.2K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive mapping of identical sequences across human proteins emphasizes the widespread issue of shared epitopes in self-antigens.

NAR genomics and bioinformatics·2026
Same author

Novel post-transcriptional dimension of glucocorticoid action through mRNA translation and P-body remodeling.

Signal transduction and targeted therapy·2026
Same author

Statical: Evaluation of an open access biostatistics tool.

Health informatics journal·2026
Same author

Predictive models for estimating the duration of labour induction: A systematic review and critical appraisal.

Midwifery·2026
Same author

Single fraction based-partial breast irradiation: 10-year results of the SiFEBI phase 2 prospective trial.

Clinical and translational radiation oncology·2026
Same author

Harnessing the lung microbiome for precision management of fibrotic lung disease.

Trends in molecular medicine·2026
Same journal

Liquid biopsy for early cancer detection in hereditary cancer syndromes: current evidence.

Critical reviews in oncology/hematology·2026
Same journal

Estrobolome and the Endocrine-Microbiome Axis in Breast and Endometrial Carcinogenesis.

Critical reviews in oncology/hematology·2026
Same journal

Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy.

Critical reviews in oncology/hematology·2026
Same journal

Neoadjuvant immunotherapy in melanoma: From pathologic response to response-adapted management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: Implications for tumor biology and therapeutic strategies - A comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance.

Critical reviews in oncology/hematology·2026
See all related articles

Related Experiment Video

Updated: Jan 22, 2026

Detecting Cortex Fragments During Bacterial Spore Germination
08:35

Detecting Cortex Fragments During Bacterial Spore Germination

Published on: June 25, 2016

9.9K

Germinal immunogenetics as a predictive factor for immunotherapy.

Sadal Refae1, Jocelyn Gal2, Patrick Brest3

  • 1Centre Antoine Lacassagne, Medical Oncology Department, University Côte d'Azur, Nice, F-06189, France.

Critical Reviews in Oncology/Hematology
|July 14, 2019
PubMed
Summary
This summary is machine-generated.

Germline variants in DNA can predict patient response and toxicity to cancer immunotherapy (CPIs). Further research is needed to understand the functional impact of these genetic markers.

Keywords:
Check-point inhibitorsGerminal immunogeneticsImmunotherapyPredictive factors

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.9K
Investigating Teliospore Germination Using Microrespiration Analysis and Microdissection
08:50

Investigating Teliospore Germination Using Microrespiration Analysis and Microdissection

Published on: May 13, 2018

7.7K

Related Experiment Videos

Last Updated: Jan 22, 2026

Detecting Cortex Fragments During Bacterial Spore Germination
08:35

Detecting Cortex Fragments During Bacterial Spore Germination

Published on: June 25, 2016

9.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.9K
Investigating Teliospore Germination Using Microrespiration Analysis and Microdissection
08:50

Investigating Teliospore Germination Using Microrespiration Analysis and Microdissection

Published on: May 13, 2018

7.7K

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Clinical response to checkpoint inhibitors (CPIs) varies significantly across patients and tumor types.
  • Biomarker research has focused on tumors and their microenvironments.
  • Host-related genetic factors are increasingly recognized as crucial for predicting treatment outcomes.

Purpose of the Study:

  • To explore the utility of germline variants as predictive biomarkers for CPI therapy efficacy and toxicity.
  • To address the challenge of understanding the functional significance of single-nucleotide polymorphisms (SNPs) associated with CPI treatment outcomes.

Main Methods:

  • Investigating host-related parameters, specifically germline variants identified through blood DNA analysis.
  • Utilizing powered calculations to optimize the balance between sample size and allele frequency for SNP analysis.
  • Leveraging new molecular technologies and analytical methods to bridge the knowledge gap.

Main Results:

  • Germline variants offer accessible indicators for expanding the spectrum of predictive markers for CPI treatment.
  • Identifying host-related parameters is a valuable strategy for predicting both treatment efficacy and toxicity.
  • There is a need to elucidate the functional impact of identified SNPs on CPI treatment response.

Conclusions:

  • Germline variants represent a promising avenue for personalized cancer immunotherapy.
  • Further investigation into the functional mechanisms of SNPs is essential for clinical application.
  • Integrating host genetics into biomarker strategies can enhance the prediction of CPI therapy outcomes.